Zim Laboratories Receives GST Demand Notice of ₹2.20 Crore
Zim Laboratories Limited received a GST Demand Notice dated December 30, 2025, for FY 2021-22. The notice from the Deputy Commissioner of State Tax, Nagpur, aggregates to ₹2.20 crore, including GST, interest, and penalty. The company is assessing the demand and plans to file an appeal, anticipating no material financial impact.
The demand notice is for a significant amount (₹2.20 crore), which could potentially impact financials if the appeal is unsuccessful. However, the company's statement of no anticipated material impact mitigates the immediate high impact.
The company received a GST demand notice, which is a negative event. However, the company is taking steps to appeal and does not anticipate a material impact, balancing the negative aspect.
Zim Laboratories Limited has disclosed the receipt of a Goods and Services Tax (GST) Demand Notice from the Office of the Deputy Commissioner of State Tax, Nagpur, Maharashtra. The notice, dated 30th December 2025, pertains to the Financial Year 2021-22 and aggregates to a total demand of ₹2,19,64,841.
The demand includes GST amounting to ₹1,68,50,472, interest of ₹34,29,322, and a penalty of ₹16,85,047. The alleged contravention relates to excess Input Tax Credit availed by the company during the specified financial year.
Zim Laboratories is undertaking appropriate steps to assess the demand and plans to file an appeal with the concerned authorities. The company stated that it does not anticipate any material impact on its financials, operations, or other activities as a result of this notice. The delay in disclosure was attributed to the time required to understand the matter and initiate follow-up actions.
What to do with a filing like this
Zim Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zim Laboratories Limited. Read the original for the full detail.